Market cap
$-- Mln
Market cap
$-- Mln
Revenue (TTM)
$1,387 Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$0 Mln
ROE
0 %
ROCE
-- %
Industry P/E
--
EV/EBITDA
0
Debt to Equity
--
Book Value
$13.1
EPS
$1.3
Face value
--
Shares outstanding
0
CFO
$349.17 Mln
EBITDA
$488.29 Mln
Net Profit
$189.24 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Apollo Medical Holdings Inc (ASTH)
| -4.1 | -6.5 | 3.5 | 0.7 | 10.1 | 13.3 | 20.9 |
|
BSE Sensex*
| -9.2 | 6.9 | -6.5 | -4.2 | 8.0 | 9.1 | 11.6 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|---|---|---|---|---|---|---|---|
|
Apollo Medical Holdings Inc (ASTH)
| 29.4 | -59.7 | 302.2 | -0.8 | -7.3 | -17.2 | 220.0 |
|
S&P Small-Cap 600
| 13.9 | -17.4 | 25.3 | 9.6 | 20.9 | -9.7 | 11.7 |
|
BSE Sensex
| 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Apollo Medical Holdings Inc (ASTH)
|
36.7 | -- | 1,386.7 | 60.7 | 7.6 | 10.5 | -- | 0.0 |
| 14.5 | 3,350.9 | 3,125.0 | -262.7 | 0.9 | -313.2 | -- | 20.5 | |
| 423.2 | 5,686.7 | 2,540.6 | 259.8 | 10.4 | 27 | 23.1 | 6.7 | |
| 107.9 | 10,138.5 | 5,935.2 | 566.2 | 18.1 | 25.1 | 18.4 | 4.2 | |
| 27.1 | 6,416.5 | 2,347.6 | 128.4 | 4.5 | 25.2 | 55.2 | 11.9 | |
| 20.3 | 4,203.8 | 5,649.5 | 207.6 | 7.0 | 15.2 | 21.2 | 3.3 | |
| 24.9 | 3,101.7 | 2,122.8 | 22.9 | 1.8 | 3.3 | 137.2 | 4.2 | |
| 57.5 | 4,374.6 | 2,040.2 | -18.7 | 5.0 | -1.9 | -- | 4.2 | |
| 15.7 | 4,405.7 | 1,163.6 | 78.0 | 26.1 | 15.4 | 57.2 | 7.3 | |
| 186.4 | 10,888.4 | 5,057.8 | 344.0 | 9.2 | 16.9 | 31.9 | 4.9 |
Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services in the United States. The company is leveraging its proprietary population health management and healthcare delivery platform,... operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was incorporated in 1985 and is headquartered in Alhambra, California. Read more
Executive Chairman
Dr. Kenneth T. Sim M.D.
President & CEO
Mr. Brandon Sim
Headquarters
Alhambra, CA
Website
The share price of Apollo Medical Holdings Inc (ASTH) is $36.72 (NASDAQ) as of 26-Apr-2024 09:30 EDT. Apollo Medical Holdings Inc (ASTH) has given a return of 10.12% in the last 3 years.
Since, TTM earnings of Apollo Medical Holdings Inc (ASTH) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2023
|
29.55
|
2.92
|
|
2022
|
28.39
|
2.36
|
|
2021
|
48.93
|
7.53
|
|
2020
|
-28.65
|
2.06
|
|
2019
|
47.89
|
3.53
|
The 52-week high and low of Apollo Medical Holdings Inc (ASTH) are Rs -- and Rs -- as of 01-May-2026.
Apollo Medical Holdings Inc (ASTH) has a market capitalisation of -- as on 26-Apr-2024. As per SEBI classification, it is a Small Cap company.
Before investing in Apollo Medical Holdings Inc (ASTH), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.